HANLIM PHARMACEUTICAL CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for HANLIM PHARMACEUTICAL CO., LTD..The latest application filed is for "2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same".

Company Profile

10.12.12

HANLIM PHARMACEUTICAL CO., LTD. - Yongin-si KR
HANLIM PHARMACEUTICAL CO., LTD. - Yongin-si, Gyeonggi-do KR
HANLIM PHARMACEUTICAL CO., LTD. - Gyeonggi-do KR
HANLIM PHARMACEUTICAL CO., LTD - Gyeonggi-Do KR
Hanlim Pharmaceutical Co., Ltd. - Seoul KR
Hanlim Pharmaceutical Co., Ltd. - 1656-10 Seocho-dong, Seocho-gu Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same Grant 11,299,478 - Kim , et al. April 12, 2	2022-04-12
2-cyanopyrimidin-4-yl Carbamate Or Urea Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same App 20210047301 - KIM; Kyung-Hee ; et al.	2021-02-18
Eye Drops In Form Of Solution Comprising Benzopyran Derivative Or Pharmaceutically Acceptable Salt Thereof App 20200405634 - SHIN; Dong-Yeop ; et al.	2020-12-31
Method for purifying benzopyran derivative, crystal form thereof, and method for preparing crystal form Grant 10,487,074 - Ryu , et al. Nov	2019-11-26
Method For Purifying Benzopyran Derivative, Crystal Form Thereof, And Method For Preparing Crystal Form App 20190248768 - RYU; Jae-Chun ; et al.	2019-08-15
Safety cap Grant D768,492 - Kim October 11, 2	2016-10-11
Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient Grant 9,301,954 - Min , et al. April 5, 2	2016-04-05
Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration Grant 8,859,531 - Lee , et al. October 14, 2	2014-10-14
Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide Grant 8,691,842 - Min , et al. April 8, 2	2014-04-08
Pharmaceutical Composition Including Mometasone Furoate And Azelastine Hydrochloride For Nasal Administration App 20130252929 - Lee; Sang-Yong ; et al.	2013-09-26
Pharmaceutical Composition For Preventing Or Treating Rheumatoid Arthritis, Containing Rebamipide App 20120172394 - Min; Jun-Ki ; et al.	2012-07-05
S-(-)-amlodipine nicotinate and process for the preparation thereof Grant 7,579,475 - Chung , et al. August 25, 2	2009-08-25
Processes for the preparation of S-(-)-amlodipine Grant 7,482,464 - Chung , et al. January 27, 2	2009-01-27
S-(-)-amlodipine Nicotinate And Process For The Preparation Thereof App 20080027227 - Chung; You Sup ; et al.	2008-01-31
S-(-)-amlodipine nicotinate and process for the preparation thereof Grant 7,279,492 - Chung , et al. October 9, 2	2007-10-09
Processes For The Preparation Of S-(-)-amlodipine App 20070155969 - Chung; You Sup ; et al.	2007-07-05
S-(-) -amlodipine nicotinate and process for the preparation thereof App 20060014795 - Chung; You Sup ; et al.	2006-01-19
Processes for the preparation of s-(-)-amlodipine App 20060014961 - Chung; You Sup ; et al.	2006-01-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.